Tom Frohlich's most recent trade in Jade Biosciences Inc was a trade of 6,000 Common Stock done at an average price of $7.4 . Disclosure was reported to the exchange on May 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jade Biosciences Inc | Tom Frohlich | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.40 per share. | 16 May 2025 | 6,000 | 6,000 | - | 7.4 | 44,400 | Common Stock |